Cargando…
Translating the promise of 5HT(4) receptor agonists for the treatment of depression
Animal experimental studies suggest that 5-HT(4) receptor activation holds promise as a novel target for the treatment of depression and cognitive impairment. 5-HT(4) receptors are post-synaptic receptors that are located in striatal and limbic areas known to be involved in cognition and mood. Consi...
Autores principales: | Murphy, Susannah E, de Cates, Angharad N, Gillespie, Amy L, Godlewska, Beata R, Scaife, Jessica C, Wright, Lucy C, Cowen, Philip J, Harmer, Catherine J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188527/ https://www.ncbi.nlm.nih.gov/pubmed/32241310 http://dx.doi.org/10.1017/S0033291720000604 |
Ejemplares similares
-
Déjà-vu? Neural and behavioural effects of the 5-HT(4) receptor agonist, prucalopride, in a hippocampal-dependent memory task
por: de Cates, Angharad N., et al.
Publicado: (2021) -
The Effect of the 5-HT(4) Agonist, Prucalopride, on a Functional Magnetic Resonance Imaging Faces Task in the Healthy Human Brain
por: de Cates, Angharad N., et al.
Publicado: (2022) -
A translational perspective on the anti-anhedonic effect of ketamine and its neural underpinnings
por: Pulcu, Erdem, et al.
Publicado: (2021) -
Pharmacological targeting of cognitive impairment in depression: recent developments and challenges in human clinical research
por: Colwell, Michael J., et al.
Publicado: (2022) -
Predicting Treatment Response in Depression: The Role of Anterior Cingulate Cortex
por: Godlewska, Beata R, et al.
Publicado: (2018)